Bibliography
Coëffier, E., Clément, J.-M., Cussac, V., Khodaei-Boorane, N., Jehanno, M., Rojas, M., Dridi, A., Latour, M., El Habib, R., Barré-Sinoussi, F., Hofnung, M., & Leclerc, C. (2000). Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Vaccine, 19(7â8), 684â693.
Authors
12
- Eliane Coëffier (first)
- Jean-Marie Clément (additional)
- Valérie Cussac (additional)
- Nasser Khodaei-Boorane (additional)
- Muguette Jehanno (additional)
- Marie Rojas (additional)
- Abel Dridi (additional)
- Mireille Latour (additional)
- Raphaëlle El Habib (additional)
- Françoise Barré-Sinoussi (additional)
- Maurice Hofnung (additional)
- Claude Leclerc (additional)
References
24
Referenced
100
10.1128/JVI.67.11.6642-6647.1993
/ J. Virol. / A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 by Muster (1993)10.1073/pnas.91.8.3348
/ Proc. Natl. Acad. Sci. USA / Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody by Conley (1994)10.1128/JVI.68.6.4031-4034.1994
/ J. Virol. / Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS by Muster (1994){'key': '10.1016/S0264-410X(00)00267-X_BIB4', 'first-page': '191', 'article-title': 'Human monoclonal antibodies against gp41 and gp120 as potential agent for passive immunization', 'volume': '92', 'author': 'Buchacher', 'year': '1992', 'journal-title': 'Vaccines'}
/ Vaccines / Human monoclonal antibodies against gp41 and gp120 as potential agent for passive immunization by Buchacher (1992)10.1128/JVI.69.11.6609-6617.1995
/ J. Virol. / Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG by Trkola (1995)10.1128/JVI.71.4.2674-2684.1997
/ J. Virol. / Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein by Earl (1997)10.1128/JVI.70.10.6751-6758.1996
/ J. Virol. / The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate by Conley (1996)10.1128/JVI.71.10.7198-7206.1997
/ J. Virol. / Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12 by Mascola (1997)10.1128/JVI.72.12.9788-9794.1998
/ J. Virol. / Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells by Frankel (1998)10.4049/jimmunol.144.8.3174
/ J. Immunol. / Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasme by Leclerc (1990)10.4049/jimmunol.147.10.3545
/ J. Immunol. / The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics by Leclerc (1991)10.1016/0378-1119(92)90667-E
/ Gene / Expression of heterelogous peptides at two permissive sites of the MalE protein: antigenicity and immunogencity of foreign B-cell and T-cell epitopes by Martineau (1992)10.3109/08830189409061720
/ Int. Rev. Immunol. / Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins by Leclerc (1994)10.1016/S0161-5890(96)00091-0
/ Mol. Immunol. / Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein by Martineau (1996)10.4049/jimmunol.158.7.3252
/ J. Immunol. / Control by Ig genes of the responsiveness to a neutralisation viral B cell epitope by Leclerc (1997)10.1016/0022-2836(87)90243-9
/ J. Mol. Biol. / Silent and functional changes in the periplasmic maltose-binding protein of Escherichia coli K12. I Transport of maltose by Duplay (1987)10.1038/nbt0291-170
/ Bio/Technology / A genetic system to elicit and monitor antipeptide antibodies without peptide synthesis by Martineau (1991)10.1016/0022-2836(87)90244-0
/ J. Mol. Biol. / Silent and functional changes in the periplasmic maltose-binding protein of Escherichia coli K12. II. Chemotaxis towards maltose by Duplay (1987)10.1016/0014-5793(93)81409-S
/ FEBS Lett. / Location of tolerated insertions/deletions in the structure of the maltose binding protein by Betton (1993)10.1016/0014-5793(78)80940-5
/ FEBS Lett. / Affinity chromatographic isolation of periplasmic maltose-binding protein of Escherichia coli by Ferency (1978)10.1097/00002030-199606000-00003
/ AIDS / Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5 by Purtscher (1996)10.1074/jbc.272.1.362
/ J. Biol. Chem. / NMR studies on the flexibility of the poliovirus C3 linear epitope inserted into different sites of the maltose-binding protein by Lecroisey (1997)10.1089/aid.1998.14.1115
/ AIDS Res. Hum. Retrovir. / Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5 by Kunert (1998)10.1099/0022-1317-77-9-2001
/ J. Gen. Virol. / Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus by Eckhart (1996)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 7:33 a.m.) |
Deposited | 2 years, 4 months ago (April 7, 2023, 3:28 a.m.) |
Indexed | 4 months, 3 weeks ago (April 10, 2025, 9:28 a.m.) |
Issued | 24 years, 10 months ago (Nov. 1, 2000) |
Published | 24 years, 10 months ago (Nov. 1, 2000) |
Published Print | 24 years, 10 months ago (Nov. 1, 2000) |
@article{Co_ffier_2000, title={Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein}, volume={19}, ISSN={0264-410X}, url={http://dx.doi.org/10.1016/s0264-410x(00)00267-x}, DOI={10.1016/s0264-410x(00)00267-x}, number={7–8}, journal={Vaccine}, publisher={Elsevier BV}, author={Coëffier, Eliane and Clément, Jean-Marie and Cussac, Valérie and Khodaei-Boorane, Nasser and Jehanno, Muguette and Rojas, Marie and Dridi, Abel and Latour, Mireille and El Habib, Raphaëlle and Barré-Sinoussi, Françoise and Hofnung, Maurice and Leclerc, Claude}, year={2000}, month=nov, pages={684–693} }